HB 1239·TN·house
Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
Signed into LawFiled Feb 6, 2025
Sponsor: Helton-Haynes
Latest Action
Pub. Ch. 295
Apr 28, 2025
Track this bill
Get real-time alerts when HB 1239 changes status, plus AI-powered summaries and stage predictions.
Sign up free